WilmerHale
Client SatisfactionLawyers
Robert Gunther
- Phone1 212 230 8830
- Email[email protected]
Work Department
Intellectual Property Litigation; Litigation; Trials; Life Sciences; Big Data
Position
Partner
Career
Robert Gunther has over 35 years of experience as a trial lawyer representing life sciences, pharmaceutical and technology clients in intellectual property and technology litigation at both the trial and appellate levels. Mr. Gunther is a Fellow of the American College of Trial Lawyers, and he has consistently been selected by Chambers USA, Managing IP magazine, LMG Life Sciences and IAM as a leading lawyer in the area of patent litigation.
Mr. Gunther has successfully tried patent, trademark, trade secret, license disputes and other intellectual property cases before numerous federal district courts, state courts and arbitration tribunals. He has also argued appeals before the US Court of Appeals for the Federal Circuit, litigated patent disputes before the US International Trade Commission and litigated inter partes review proceedings before the Patent Trial and Appeal Board of the US Patent and Trademark Office.
Mr. Gunther has handled cases involving an array of technologies, including biotechnology, pharmaceuticals, medical devices, financial methodologies, petrochemical processes, computer hardware and software, telecommunications and networking, video game and graphic display hardware and software, optical discs and consumer products, among others. His intellectual property clients have included Abbott Laboratories, Affymetrix, Ariosa, Cephalon, Chugai Pharmaceutical, Eastman Kodak Company, Genentech, Memorial Sloan Kettering Cancer Center, Mentor Graphics, Nintendo, Playtex Products, QinetiQ, Reckitt Benckiser, Roche Diabetes Care, Roche Molecular Systems, Sumitomo Electric, Swatch / Omega and WebMD.
Most recently, during May / June 2022, Mr. Gunther led a trial team that successfully defended Reckitt Benckiser against claims of fraud and trade secret misappropriation relating to an over-the-counter pharmaceutical product in federal court in Newark, New Jersey. Following a four week trial, the jury unanimously ruled in favor of Reckitt on all issues.
From 2018 to 2021, Mr. Gunther was a member of WilmerHale's Management Committee.
Education
St. John's University School of Law , J.D. (1984) St. John's University , B.A. (1981)